Page 54 - ஆல்பர்ட் ஐன்ஸ்டீன் கல்லூரி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Reflections on our COVID year from New Rochelle, the nation s pandemic ground zero – The Forward
forward.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forward.com Daily Mail and Mail on Sunday newspapers.
Anti-CD20s Linked to Higher COVID-19 Severity in MS
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Brickell Biotech To Host Key Opinion Leader Webinar on the Hyperhidrosis Market
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
E-Mail
DALLAS, March 4, 2021 The rate of cardiovascular risk factors among Hispanic/Latino people living in the U.S. is very high, and while they are often aware of their health conditions, less than half of the Hispanic/Latino adults with history of stroke or transient ischemic attack (TIA) had healthy blood pressure and cholesterol, and about half had healthy blood sugar levels, according to new research published today in
Stroke, a journal of the American Stroke Association, a division of the American Heart Association.
According to the American Heart Association, from 2015 to 2018, 52.3% of Hispanic men and 42.7% of Hispanic women aged 20 years and older had cardiovascular disease (CVD).
Viracta Therapeutics Strengthens Company Leadership with New Appointments to the Board of Directors and Management Team
Stephen Rubino, Ph.D., MBA and Barry J. Simon, M.D. appointed to the Board of Directors
Cheryl A. Madsen, RAC appointed as Senior Vice President, Regulatory Affairs
News provided by
Share this article
Share this article
SAN DIEGO, March 4, 2021 /PRNewswire/ Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced that it has strengthened its leadership team with the appointments of Drs. Stephen Rubino and Barry J. Simon to the Board of Directors, the addition of Cheryl A. Madsen, RAC as Senior Vice President, Regulatory Affairs, and the promotion of several members of the management team.